Evolent Health (EVH) Other financing activities (2015 - 2024)

Evolent Health's Other financing activities history runs 10 years deep, the most recent figure standing at -$1000.0 for Q4 2024.

• On a quarterly basis, Other financing activities fell 100.03% year-over-year to -$1000.0 in Q4 2024; TTM through Sep 2025 was -$1000.0, a 100.01% decrease from a year earlier, with the FY2024 full-year figure at $3.5 million, down 72.35% from the prior year.
• Other financing activities fell to -$1000.0 in Q4 2024 per EVH's latest filing, from $2.3 million in the prior quarter.
• Across five years, Other financing activities topped out at $6.5 million in Q1 2021 and bottomed at -$1000.0 in Q4 2024.
• The 5-year median for Other financing activities is $1.6 million (2023), against an average of $1.9 million.
• Across the five-year window, Other financing activities jumped 7659.52% in 2021 and plunged 100.03% in 2024, its largest moves.
• Year by year, Other financing activities stood at $603000.0 in 2020, then soared by 185.74% to $1.7 million in 2021, then slumped by 31.98% to $1.2 million in 2022, then soared by 184.64% to $3.3 million in 2023, then slumped by 100.03% to -$1000.0 in 2024.
• Per Business Quant, the three latest EVH Other financing activities figures stand at -$1000.0 (Q4 2024), $2.3 million (Q3 2024), and $61000.0 (Q2 2024).